One-Third of YouTube Hay Fever Videos Are Misleading

THURSDAY, Aug. 18, 2022 (HealthDay News) -- Less than half of YouTube videos on allergic rhinitis provide useful information, according to a study published online July 13 in the Annals of Allergy, Asthma & Immunology.
Celine Lund-Nielsen Remvig, from the University of Copenhagen in Denmark, and colleagues examined the popularity and usefulness of YouTube videos on allergic rhinitis. Eighty-six videos were included in the analysis.
The researchers found that 43 percent of the videos were classified as useful, 36 percent as misleading, and 21 percent as neither useful nor misleading. Only 17.5 percent of the videos were uploaded by a specialist, medical doctor, or health care provider, while 39.5 percent were uploaded from a TV show or YouTube channel. User interaction was greater for videos uploaded by TV shows and YouTube channels, which accounted for 66.9 percent of the total likes, 66.8 percent of the total dislikes, and 54.0 percent of the total comments. While this source alone accounted for 23.4 percent of the total views, it accounted for 48 percent of the total misleading videos.
"According to research, 70 percent of patients with a chronic disease are influenced by information they get from online sources, and one-quarter of internet users have watched an online video about a health or medical problem," Remvig said in a statement. "In reviewing YouTube videos on the topic of allergic rhinitis, we found that less than half of the videos provided useful information."
Several authors disclosed financial ties to pharmaceutical companies.
Related Posts
Flu Shot Season Is Here: Why You (and Your Kids) Need One
SATURDAY, Oct. 7, 2023 (HealthDay News) -- It’s time to get the flu shot....
One in Four Patients in ICU Receive Red Blood Cell Transfusion
MONDAY, Oct. 16, 2023 (HealthDay News) -- For patients admitted to intensive...
Cognitive Behavioral Therapy Aids Outcomes One Year After Bariatric Surgery
FRIDAY, Aug. 4, 2023 (HealthDay News) -- Telephone-based cognitive behavioral...
Atogepant Prevents Migraine in Adults
WEDNESDAY, June 15, 2022 (HealthDay News) -- Atogepant appears to be effective...
